Asston Pharmaceuticals share news, announcements and annual reports
BSE: 544445Pharmaceuticals & BiotechnologySmall Cap
ASSTON PHARMACEUTICALS LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2025
Last close ₹150.72up ₹0.02 (0.01%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹150.70.
30 Oct: open ₹152.00, high ₹153.40, low ₹146.00
52-week range of traded prices to 30 Oct 2026
₹60.00Low, 21 Jul 2026₹153.40High, 30 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹165 Cr3,188th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 318.43
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 42.59
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 1.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 9.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,000
Asston Pharmaceuticals board meetings
30 filed, newest first.
Oct 2026
13 Oct · Board meeting
6 Oct · Board meeting
Meeting on 13 Oct 2026
Sep 2026
5 Sep · Board meeting
4 Sep · Board meeting
Aug 2026
27 Aug · Board meeting
Meeting on 4 Sep 2026: annual general meeting
Jul 2026
2 Jul · Board meeting
2 Jul · Board meeting
Jun 2026
24 Jun · Board meeting
Meeting on 2 Jul 2026: preferential issue of shares
May 2026
21 May · Board meeting
Meeting on 29 May 2026: audited results
Mar 2026
30 Mar · Board meeting
25 Mar · Board meeting
Meeting on 30 Mar 2026
Feb 2026
7 Feb · Board meeting
Jan 2026
29 Jan · Board meeting
Meeting on 7 Feb 2026: increase in authorised capital5 Jan · Board meeting
2 Jan · Board meeting
Meeting on 5 Jan 2026
Nov 2025
11 Nov · Board meeting
Meeting on 14 Nov 2025: half yearly results
Oct 2025
16 Oct · Board meeting
13 Oct · Board meeting
Meeting on 16 Oct 2025
Aug 2025
25 Aug · Board meeting
21 Aug · Board meeting
Meeting on 25 Aug 2025: annual general meeting